Publication | Open Access

Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)

OncologyClinical TranslationMedicineEureka RegistryPharmacotherapyDeep Molecular ResponseEuropean SurveyPharmacologyRadiation OncologyNovel Therapy